SAN DIEGO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating the acquisition of Thoughtworks Holding, Inc. (NASDAQ: TWKS) by an affiliate of funds advised by Apax Partners LLP, which will purchase all of the outstanding shares of Thoughtworks common stock that they do not already own.    If you own shares of Thoughtworks, submit a form, email attorney Aaron Dumas, Jr. or give us a call at (800) 350-6003.    Is the Proposed Acquisition Best for Thoughtworks Holding, ...

CALGARY, Alberta, Sept. 18, 2024 (GLOBE NEWSWIRE) -- MPIC Fund I LP ("MPIC") announces that it has filed an early warning report (the "Early Warning Report") under National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues in connection with the closing of the previously announced reverse takeover (the "Transaction" or the "RTO") whereby MPIC acquired shares of Premier Diversified Holdings Inc. (the "Company" or "PDH"). In connection with the RTO (i) AJA Hea ...

The S&P 500 continues to shake off recent concerns and charge higher, now sitting at nearly a 20% gain for the year. Against this backdrop, I continue to recommend rotating more of your portfolio toward lesser-known value stocks that have fallen this year and, inWith combined experience of covering technology companies on Wall Street and working in Silicon Valley, and serving as an outside adviser to several seed-round startups, Gary Alexander has exposure to many of the themes shaping the industry today. H ...

Since my first Tesla, Inc. (NASDAQ: TSLA ) article ( Tesla’s iPhone Moment ) shares have rallied sharply. However, it’ll be difficult for shares to rally further until the company moves into its next growth-phase. A key driver could be Tesla’s transition toDom received his MBA in Management and B.S. Finance (Manhattan College) and was credit trained at New York University. Dom received the Financial Risk Manager (FRM) designation from GARP.Areas of expertise are: Exponential Age & SaaS software and Blockcha ...

A looming threat from a very powerful rival could significantly dampen a key business for the company.Healthcare technology company ResMed's (RMD -5.12%) stock wasn't quite the picture of health on Wednesday. The shares lost more than 5% of their value on news of an analyst's downgrade and his new, bearish outlook. That performance didn't look good against that of the S&P 500 index, which fell a comparatively light 0.3%.A change in recommendation for the worseWell before market open that day, Wolfe Research ...

Michael McCraeMichael McCrae is leading Kitco's coverage of the mining sector. McCrae, who has both an MBA and CMA, knows how to build digital media properties. He was co-founder and publisher of MINING.com, an award-winning news site. Before coming to media, McCrae worked in IT and banking. Please reach out: mmccrae@kitco.com or (514) 670-1383. You can also follow him at @michaelmccrae.Paul Harris Paul has more than 20 years of experience in the mining sector in investor relations, communications, research ...

NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Paragon 28, Inc. (NYSE: FNA) resulting from allegations that Paragon 28 may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Paragon 28 securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement ...

– Trial met its primary endpoint across all dose cohorts with 74% of patients at the 0.3 mg/kg every 2 weeks dose achieving a complete or partial response within the first six months of treatment –– Niktimvo approved by U.S. FDA for the treatment of chronic graft-versus-host disease after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg –– Niktimvo added to latest NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the treatment ...

PALMDALE, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Northrop Grumman’s B-21 Raider program is making great progress as the team executes a robust flight test campaign and scales into production. In collaboration with the U.S. Air Force, Northrop Grumman’s program management approach on B-21 centers around producibility and adoption of digital technology to ultimately deliver an effective, affordable system to the warfighter that is adaptable to future threats. As the B-21 Raider flight test program progre ...

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. The content in this article is for informational, educational, and entertainment purposes only. This ...